aeruginosa icaac 2012 finalprogram web4a

281 ORAL SESSIONS Final Program Oral Sessions- Cateogry C1 Antibacterials: Mechanisms of Action, Biochemistry and Genetics of Resistance Antibacterial, not Viral or Fungal Oral Sessions- Category C2 Antibacterials: Surveys andor Molecular Epidemiology of Resistance and Resistance Genes, Strains or Serotypes Bacterial, not Viral or Fungal Resistance Sunday PM Symposium 037 Multidrug Resistance in Emerging Countries Esplanade Ballroom 302 4:00 p.m. - 6:00 p.m. Slide Session 047 Structure Function Esplanade Ballroom 300 4:00 p.m. - 6:30 p.m. Monday AM Symposium 064 Plasmid- Mediated Quino- lone Resistance Esplanade Ballroom 302 8:30 a.m. - 10:30 a.m. Slide Session 081 Carbapenemase in Enterobacteriaceae and

P. aeruginosa

Room 122 11:15 a.m. - 12:45 p.m. Monday PM Tuesday AM Symposium 149 Novel Tech- niques for the Diagnostic of the Emerging Antibiotic Resistances Esplanade Ballroom 302 8:30 a.m. - 10:30 a.m. Slide Session 156 Extended Spec- trum ơ-Lactamases Room 121 8:30 a.m. - 11:00 a.m. Slide Session 197 Resistance in Staphylococcus aureus Room 122 11:15 a.m. - 12:45 p.m. Tuesday PM Symposium 203 Bacterial Communication and Resistance Esplanade Ballroom 300 2:00 p.m. - 4:00 p.m. Meet-the-Experts 214 Top 10 ơ-Lactamase Papers in 2012 Esplanade Ballroom 305 5:45 p.m. - 7:00 p.m. Wednesday AM Symposium 228 Resistance in Beyond MecA Esplanade Ballroom 302 9:15 a.m. - 11:15 a.m. Sunday PM Symposium 038 Whole Genome Sequencing and Molecular Epide- miology: The New Frontier? Esplanade Ballroom 308 4:00 p.m. - 6:00 p.m. Monday AM Symposium 065 Population Dynamics in Streptococcus pneumoniae Esplanade Ballroom 310 8:30 a.m. - 10:30 a.m. Monday PM Symposium 123 Antibiotic Com- binations against Gram-Negatives in the XDR Era: From Bench to Bedside Room 122 2:00 p.m. - 4:00 p.m. Meet-the-Experts 132 Detecting, Controlling, and Treating Carbapen- emase-Producing Enterobacteriaceae Esplanade Ballroom 302 5:45 p.m. - 7:00 p.m. Tuesday AM Meet-the-Experts 140 : The Manage- ment of Severe and Recurrent Infec- tions Esplanade Ballroom 308 7:00 a.m. - 8:15 a.m. Slide Session 157 Carbapenemas- es Go Global Esplanade Ballroom 300 8:30 a.m. - 11:00 a.m. Tuesday PM Symposium 204 Global Spread of Antimicrobial Resistance: Mecha- nisms of Spread, Surveillance, and Control Room 121 2:00 p.m. - 4:00 p.m. Meet-the-Experts 215 Surveillance of Antimicrobial Re- sistance: Potential Sources of Bias Esplanade Ballroom 309 5:45 p.m. - 7:00 p.m. Wednesday AM Meet-the-Experts 220 Anaerobes and Surveillance: Neglected or Not? Esplanade Ballroom 302 7:00 a.m. - 8:15 a.m. Slide Session 236 Acinetobacter: Challenges and Continued Emergence Room 132 9:15 a.m. - 11:45 a.m. Slide Session 237 MRSA: Pervasive, Persistent, and Pathogenic Esplanade Ballroom 305 9:15 a.m. - 11:45 a.m. 282 Oral Sessions September 9-12 | Oral Sessions- Category D Laboratory Tests for Diagnosing Infections; Methods for Antibacterial Susceptibility Testing Oral Sessions- Category E In Vitro Antibacterial Susceptibility Studies and Drug-Combination Interactions Sunday PM Symposium 039 Best Practices: Diagnosis of Viral Causes of Hepatitis Esplanade Ballroom 305 4:00 p.m. - 6:00 p.m. Monday AM Meet-the-Experts 050 Syphilis Diag- nostics: Traditional Versus “New” Algo- rithm Room 122 7:00 a.m. - 8:15 a.m. Interactive Symposium 060 Cases in Clini- cal Microbiology Room 103 8:30 a.m. - 10:30 a.m. Monday PM Symposium 124 Epidemiology and Diagnosis of Febrile Illness in the Era of Global Climate Change Room 102 2:00 p.m. - 4:00 p.m. Meet-the-Experts 133 MALDI-ToF and PCRESI Mass Spectrometry: Implementation and Impact on Patient Care Room 121 5:45 p.m. - 7:00 p.m. Tuesday AM Symposium 150 Antimicro- bial Susceptibility Update Room 120 8:30 a.m. - 10:30 a.m. Tuesday PM Slide Session 201 Diverse Ap- plications of Mass Spectrometry in Clinical Microbiol- ogy Room 120 1:30 p.m. - 4:00 p.m. Wednesday AM Meet-the-Experts 221 Optimal Diag- nostic Testing for Clostridium difficile in Clinical Practice Esplanade Ballroom 310 7:00 a.m. - 8:15 a.m. Interactive Symposium 226 Challenges in the Diagnosis and Clinical Interpreta- tion of Infections with Gram-Positive Rods Room 104 9:15 a.m. - 11:15 a.m Sunday PM Symposium 040 Origins and Ecology of Antibi- otic Resistance Esplanade Ballroom 310 4:00 p.m. - 6:00 p.m. Monday AM Monday PM Tuesday AM Symposium 151 Laboratory Ap- proaches for Detec- tion, Characteriza- tion, and Reporting of Important Resis- tance Mechanisms in Gram-Negatives Room 132 8:30 a.m. - 10:30 a.m. Tuesday PM Symposium 205 Selecting Antibiotic Resistant Mutants in the Laboratory: How Best to Mimic the Real World? Esplanade Ballroom 302 2:00 p.m. - 4:00 p.m. Wednesday AM 283 ORAL SESSIONS Final Program Oral Sessions- Category G Adult and Pediatric Vaccine Studies and Pediatric Infections Oral Sessions-Category F New Antimicrobial Agents i.e. pre-US IND or prior to the start of any clinical therapeutic studies and New Research Technologies Sunday PM Symposium 042 Vaccine Conquests and Challenges Room 120 4:00 p.m. - 6:00 p.m. Monday AM Meet-the-Experts 051 Antibiotic Shortages, Anti- biotic Stewardship and the Sick Child Esplanade Ballroom 309 7:00 a.m. - 8:15 a.m. Symposium 067 Hot Topics in Vaccines Room 120 8:30 a.m. - 10:30 a.m. Symposium 077 Vaccine Innovations Esplanade Ballroom 305 11:15 a.m. - 12:45 p.m. Monday PM Slide Session 114 Vaccines: Innovations, Impact and Safety Room 121 1:30 p.m. - 4:00 p.m. Tuesday AM Meet-the-Experts 142 Healthy Mother, Healthy Baby Esplanade Ballroom 309 7:00 a.m. - 8:15 a.m. Interactive Sym- posium 145 Interactive Cases in Pediatric Infectious Diseases Room 103 8:30 a.m. - 10:30 a.m. Slide Session 198 Global Pediatrics Esplanade Ballroom 309 11:15 a.m. - 12:45 p.m. Tuesday PM Symposium 207 Hot Topics in Pediatric Infectious Disease: 2012 Room 122 2:00 p.m. - 4:00 p.m. Wednesday AM Symposium 230 Interplay between Pathogen and Host: From Immune Deficiency to Infectious Disease Room 122 9:15 a.m. - 11:15 a.m. Sunday PM Symposium 041 New Treatments for Mycobacterium tuberculosis Infections Room 122 4:00 p.m. - 6:00 p.m. Monday AM Symposium 066 Host Defense Antimicrobial Peptides: Major Players in Health and Novel Therapeutics Esplanade Ballroom 300 8:30 a.m. - 10:30 a.m. Monday PM Symposium 125 Alternative Approaches to Inhibiting Gram- Negative Bacteria Esplanade Ballroom 308 2:00 p.m. - 4:00 p.m. Tuesday AM Meet-the-Experts 141 Too Few New Anti-Gram- Negative Agents: How to Change the Landscape? Room 122 7:00 a.m. - 8:15 a.m. Tuesday PM Symposium 206 Iron Transport and Homeostasis: Are There Opportunities for New Drugs? Esplanade Ballroom 309 2:00 p.m. - 4:00 p.m. Meet-the-Experts 216 Meeting the Challenge of Efflux from Gram-Nega- tive Bacteria Esplanade Ballroom 302 5:45 p.m. - 7:00 p.m. Wednesday AM Symposium 229 New Approaches in the Treatment of Fungal Infections Esplanade Ballroom 309 9:15 a.m. - 11:15 a.m 284 Oral Sessions September 9-12 | Oral Sessions- Category H HIVAIDS and Other Retroviruses, Including Resistance Oral Sessions- Category H2 Antiretroviral Agents for Treatment and Prevention Including Preclinical and All Phases of Clinical Trials and Resistance Sunday PM Symposium 043 Update on HIV- Associated Co-Morbidities Room 121 4:00 p.m. - 6:00 p.m. Monday AM Meet-the-Experts 052 How Do I Treat HCV in HIV HCV Co-Infected Patients? Room 121 7:00 a.m. - 8:15 a.m. Slide Session 073 New Antiret- roviral Therapy: Bench to Bedside Room 104 8:30 a.m. - 11:00 a.m. Monday PM Symposium 126 Current Issues in HIV-Associated Opportunistic Diseases Esplanade Ballroom 306 2:00 p.m. - 4:00 p.m. Meet-the-Experts 134 Prevention of Anal Cancer in HIV-Infection: From Early Detec- tion to Vaccination Esplanade Ballroom 309 5:45 p.m. - 7:00 p.m. Tuesday AM Meet-the-Experts 143 Management of Antiretroviral Therapy-Induced Bone Toxicity Room 121 7:00 a.m. - 8:15 a.m. Symposium 152 What’s New in Antiretroviral Therapy Room 130 8:30 a.m. - 10:30 a.m. Tuesday PM Wednesday AM Meet-the-Experts 222 Can We Safely Simplify Antiretroviral Therapy in Treatment- Experienced Patients? Esplanade Ballroom 300 7:00 a.m. - 8:15 a.m. Slide Session 238 Common Pathogens: Still a Problem in HIV-I Room 102 9:15 a.m. - 11:45 a.m. Sunday PM Monday AM Monday PM Tuesday AM Tuesday PM Interactive Symposium 202 Advances in HIV and HCV Management Room 103 2:00 p.m. - 4:00 p.m. Wednesday AM 285 ORAL SESSIONS Final Program Oral Sessions- Cateogry K Healthcare-Associated and Surgical Infections and Clinical Epidemiology Sunday PM Slide Session 048 Difficulties of Clostridium difficile Room 254 4:00 p.m. - 6:30 p.m. Monday AM Meet-the-Experts 053 Infection Prevention and Control in Low- and -Middle- Resource Settings Esplanade Ballroom 308 7:00 a.m. - 8:15 a.m. Meet-the-Experts 054 Top Papers in Infection Prevention and Control, 2011-2012 Room 120 7:00 a.m. - 8:15 a.m. Symposium 068 Preventing Spread of

M. tuberculosis in Healthcare